Network-1 Q1 Zero Revenue, $511K Loss; ILiAD Gain Tops $1M
Network-1 posted zero revenue and a $511,000 net loss in Q1 2026, driven by rising litigation expenses and securities losses. The company booked a $1.052 million ILiAD investment gain and saw the Federal Circuit revive its Cox patent infringement case against Google.
1. Q1 Financial Results
Network-1 reported no revenue for the quarter ended March 31, 2026 and a net loss of $511,000, or $0.02 per share, compared to $150,000 revenue and a $363,000 net loss in Q1 2025. Operating expenses increased to $1,415,000 from $795,000, driven by $625,000 in litigation-related professional fees and a $100,000 reduction in interest and dividend income.
2. ILiAD Investment Gain
During the quarter Network-1 remeasured its investment in ILiAD Biotechnologies after ILiAD’s $115 million financing, transitioning from equity to cost method and recognizing a $1,052,000 gain. Realized and unrealized losses on marketable securities amounted to $287,000 due to higher short-term Treasury yields, compared with $149,000 gains in Q1 2025.
3. Patent Litigation Update
The U.S. Court of Appeals for the Federal Circuit overturned a non-infringement judgment related to Patent No. 8,205,237, remanding the Cox patent case against Google and YouTube to district court. The Patent Trial and Appeal Board denied institution of six Inter Partes Reviews filed by Samsung against Network-1’s M2M/IoT patent portfolio.
4. Liquidity, Dividends and Buybacks
As of March 31, cash, equivalents and marketable securities totaled $34.6 million, with working capital of $33.7 million, supporting dividend payments of $0.05 per share and an average repurchase price of $1.36 on 60,996 shares in Q1. Since 2011, Network-1 has returned over $45.8 million to shareholders through dividends and share repurchases.